MX2008002414A - 1h-imidazopiridinas sustituidas con hidroxi y procedimientos. - Google Patents
1h-imidazopiridinas sustituidas con hidroxi y procedimientos.Info
- Publication number
- MX2008002414A MX2008002414A MX2008002414A MX2008002414A MX2008002414A MX 2008002414 A MX2008002414 A MX 2008002414A MX 2008002414 A MX2008002414 A MX 2008002414A MX 2008002414 A MX2008002414 A MX 2008002414A MX 2008002414 A MX2008002414 A MX 2008002414A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- hydroxy substituted
- compounds
- imidazopyridines
- hydroxy
- Prior art date
Links
- 125000002887 hydroxy group Chemical group [H]O* 0.000 title abstract 2
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical class C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000001613 neoplastic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71370405P | 2005-09-02 | 2005-09-02 | |
| PCT/US2006/034427 WO2007028129A1 (en) | 2005-09-02 | 2006-09-01 | Hydroxy substituted 1h-imidazopyridines and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2008002414A true MX2008002414A (es) | 2008-03-27 |
Family
ID=37561219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2008002414A MX2008002414A (es) | 2005-09-02 | 2006-09-01 | 1h-imidazopiridinas sustituidas con hidroxi y procedimientos. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20100152230A1 (https=) |
| EP (1) | EP1924581A1 (https=) |
| JP (1) | JP4584335B2 (https=) |
| KR (1) | KR20080031496A (https=) |
| CN (1) | CN101253173A (https=) |
| AU (1) | AU2006287157A1 (https=) |
| BR (1) | BRPI0615250A2 (https=) |
| CA (1) | CA2620933A1 (https=) |
| CR (1) | CR9781A (https=) |
| EA (1) | EA200800396A1 (https=) |
| EC (1) | ECSP088225A (https=) |
| IL (1) | IL189262A0 (https=) |
| MA (1) | MA29759B1 (https=) |
| MX (1) | MX2008002414A (https=) |
| NO (1) | NO20081393L (https=) |
| RS (1) | RS20080128A (https=) |
| SV (1) | SV2009002832A (https=) |
| TN (1) | TNSN08099A1 (https=) |
| WO (1) | WO2007028129A1 (https=) |
| ZA (1) | ZA200801645B (https=) |
Families Citing this family (75)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040265351A1 (en) | 2003-04-10 | 2004-12-30 | Miller Richard L. | Methods and compositions for enhancing immune response |
| BRPI0413558A (pt) | 2003-08-12 | 2006-10-17 | 3M Innovative Properties Co | compostos contendo imidazo substituìdo por hidroxilamina |
| MXPA06002199A (es) | 2003-08-27 | 2006-05-22 | 3M Innovative Properties Co | Imidazoquinolinas sustituidas con grupos ariloxi o arilalquilenoxi. |
| CA2537763A1 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for cd5+ b cell lymphoma |
| CA2540541C (en) | 2003-10-03 | 2012-03-27 | 3M Innovative Properties Company | Alkoxy substituted imidazoquinolines |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| TW200526656A (en) | 2003-10-03 | 2005-08-16 | 3M Innovative Properties Co | Pyrazolopyridines and analogs thereof |
| US7897767B2 (en) | 2003-11-14 | 2011-03-01 | 3M Innovative Properties Company | Oxime substituted imidazoquinolines |
| WO2005048945A2 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
| WO2005051317A2 (en) | 2003-11-25 | 2005-06-09 | 3M Innovative Properties Company | Substituted imidazo ring systems and methods |
| JP2007517035A (ja) | 2003-12-29 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン |
| EP1699788A2 (en) | 2003-12-30 | 2006-09-13 | 3M Innovative Properties Company | Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides |
| WO2005094531A2 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| US7915281B2 (en) | 2004-06-18 | 2011-03-29 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
| US8541438B2 (en) | 2004-06-18 | 2013-09-24 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| ATE555786T1 (de) | 2004-09-02 | 2012-05-15 | 3M Innovative Properties Co | 1-alkoxy 1h-imidazo-ringsysteme und verfahren |
| AU2005326708C1 (en) | 2004-12-30 | 2012-08-30 | 3M Innovative Properties Company | Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
| JP5543068B2 (ja) | 2004-12-30 | 2014-07-09 | スリーエム イノベイティブ プロパティズ カンパニー | キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物 |
| WO2006084251A2 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune reponse modifiers |
| ES2475728T3 (es) | 2005-02-09 | 2014-07-11 | 3M Innovative Properties Company | Tiazoloquinolinas y tiazolonaftiridinas sustituidas con alcoxi |
| AU2006338521A1 (en) | 2005-02-09 | 2007-10-11 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods |
| CA2597587A1 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods |
| CA2597446A1 (en) | 2005-02-11 | 2006-08-31 | Coley Pharmaceutical Group, Inc. | Substituted imidazoquinolines and imidazonaphthyridines |
| CA2598695A1 (en) | 2005-02-23 | 2006-09-21 | Coley Pharmaceutical Group, Inc. | Hydroxyalkyl substituted imidazoquinolines |
| WO2006091647A2 (en) | 2005-02-23 | 2006-08-31 | Coley Pharmaceutical Group, Inc. | Method of preferentially inducing the biosynthesis of interferon |
| CA2598656A1 (en) | 2005-02-23 | 2006-08-31 | Coley Pharmaceutical Group, Inc. | Hydroxyalkyl substituted imidazoquinoline compounds and methods |
| JP2008538550A (ja) | 2005-04-01 | 2008-10-30 | コーリー ファーマシューティカル グループ，インコーポレイテッド | ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての１−置換ピラゾロ（３，４−ｃ）環状化合物 |
| JP2008535832A (ja) | 2005-04-01 | 2008-09-04 | コーリー ファーマシューティカル グループ，インコーポレイテッド | ピラゾロピリジン−１，４−ジアミン、およびそのアナログ |
| ZA200803029B (en) | 2005-09-09 | 2009-02-25 | Coley Pharm Group Inc | Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods |
| EA200800782A1 (ru) | 2005-09-09 | 2008-08-29 | Коли Фармасьютикал Груп, Инк. | ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ |
| KR20080083270A (ko) | 2005-11-04 | 2008-09-17 | 콜레이 파마시티컬 그룹, 인코포레이티드 | 하이드록시 및 알콕시 치환된 1에이치 이미다조퀴놀린 및방법 |
| WO2007093901A1 (en) | 2006-02-17 | 2007-08-23 | Pfizer Limited | 3 -deazapurine derivatives as tlr7 modulators |
| EP1988896A4 (en) | 2006-02-22 | 2011-07-27 | 3M Innovative Properties Co | CONJUGATES TO MODIFY IMMUNE REACTIONS |
| WO2007106854A2 (en) | 2006-03-15 | 2007-09-20 | Coley Pharmaceutical Group, Inc. | Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods |
| US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
| WO2008030511A2 (en) | 2006-09-06 | 2008-03-13 | Coley Pharmaceuticial Group, Inc. | Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes |
| US20080149123A1 (en) | 2006-12-22 | 2008-06-26 | Mckay William D | Particulate material dispensing hairbrush with combination bristles |
| US20100120799A1 (en) | 2007-02-19 | 2010-05-13 | Smithkline Beecham Corporation | Purine derivatives as immunomodulators |
| EP1997805A1 (en) * | 2007-06-01 | 2008-12-03 | Commissariat à l'Energie Atomique | Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans |
| CA2707030A1 (en) * | 2007-08-03 | 2009-02-12 | Pfizer Limited | Imidazopyridinones |
| US8802684B2 (en) | 2008-08-11 | 2014-08-12 | Glaxosmithkline Llc | Adenine derivatives |
| UA103195C2 (uk) | 2008-08-11 | 2013-09-25 | Глаксосмитклайн Ллк | Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань |
| EP2326646B1 (en) | 2008-08-11 | 2013-07-31 | GlaxoSmithKline LLC | Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| SI2320905T1 (sl) | 2008-08-11 | 2017-10-30 | Glaxosmithkline Llc Corporation Service Company | Novi adeninski derivati |
| ES2467108T3 (es) | 2008-12-09 | 2014-06-11 | Gilead Sciences, Inc. | Moduladores de receptores tipo toll |
| US20130018033A1 (en) | 2009-08-28 | 2013-01-17 | Array Biopharma Inc. | Raf inhibitor compounds and methods of use thereof |
| US8962652B2 (en) * | 2009-10-22 | 2015-02-24 | Gilead Sciences, Inc. | Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections |
| US8575340B2 (en) | 2010-02-10 | 2013-11-05 | Glaxosmithkline Llc | Purine derivatives and their pharmaceutical uses |
| ES2617451T3 (es) | 2010-08-17 | 2017-06-19 | 3M Innovative Properties Company | Composiciones lipidadas de compuestos modificadores de la respuesta inmunitaria, formulaciones, y métodos |
| WO2012167088A1 (en) | 2011-06-03 | 2012-12-06 | 3M Innovative Properties Company | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
| EP3153180A1 (en) | 2011-06-03 | 2017-04-12 | 3M Innovative Properties Company | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
| SI2734186T1 (sl) | 2011-07-22 | 2018-11-30 | Glaxosmithkline Llc | Sestavek |
| CN103450198B (zh) * | 2012-05-29 | 2015-07-08 | 首都医科大学 | 咪唑并吡啶并咪唑-3-取代乙酸苄酯、其合成、抗肿瘤活性及应用 |
| ES2653254T3 (es) | 2012-08-24 | 2018-02-06 | Glaxosmithkline Llc | Compuestos de pirazolopirimidina |
| KR20150085081A (ko) | 2012-11-20 | 2015-07-22 | 글락소스미스클라인 엘엘씨 | 신규 화합물 |
| US9550785B2 (en) | 2012-11-20 | 2017-01-24 | Glaxosmithkline Llc | Pyrrolopyrimidines as therapeutic agents for the treatment of diseases |
| MX358025B (es) | 2012-11-20 | 2018-08-02 | Glaxosmithkline Llc Star | Compuestos novedosos. |
| CA2960436C (en) | 2014-09-16 | 2021-01-05 | Gilead Sciences, Inc. | Solid forms of a toll-like receptor modulator |
| EP3728255B1 (en) | 2017-12-20 | 2022-01-26 | 3M Innovative Properties Company | Amide substituted imidazo[4,5-c]quinoline compounds with a branched chain linking group for use as an immune response modifier |
| WO2019209811A1 (en) | 2018-04-24 | 2019-10-31 | Bristol-Myers Squibb Company | Macrocyclic toll-like receptor 7 (tlr7) agonists |
| US11554120B2 (en) | 2018-08-03 | 2023-01-17 | Bristol-Myers Squibb Company | 1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor |
| JP2023512204A (ja) | 2020-01-27 | 2023-03-24 | ブリストル－マイヤーズ スクイブ カンパニー | トール様受容体７（ＴＬＲ７）アゴニストとしての１Ｈ－ピラゾロ［４，３－ｄ］ピリミジン化合物 |
| CN115151546A (zh) | 2020-01-27 | 2022-10-04 | 百时美施贵宝公司 | 作为Toll样受体7(TLR7)激动剂的C3-取代的1H-吡唑并[4,3-d]嘧啶化合物 |
| WO2021154663A1 (en) | 2020-01-27 | 2021-08-05 | Bristol-Myers Squibb Company | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS |
| US12485123B2 (en) | 2020-01-27 | 2025-12-02 | Bristol-Myers Squibb Company | 1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists |
| US20230131192A1 (en) | 2020-01-27 | 2023-04-27 | Bristol-Myers Squibb Company | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS |
| US20230348468A1 (en) | 2020-01-27 | 2023-11-02 | Bristol-Myers Squibb Company | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS |
| KR20220132589A (ko) | 2020-01-27 | 2022-09-30 | 브리스톨-마이어스 스큅 컴퍼니 | 톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물 |
| US20230144824A1 (en) | 2020-01-27 | 2023-05-11 | Bristol-Myers Squibb Company | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS |
| KR20220132601A (ko) | 2020-01-27 | 2022-09-30 | 브리스톨-마이어스 스큅 컴퍼니 | 톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물 |
| GB202014404D0 (en) * | 2020-09-14 | 2020-10-28 | Cambridge Entpr Ltd | Method for labelling nucleic acid |
| WO2022161420A1 (zh) * | 2021-01-28 | 2022-08-04 | 上海翊石医药科技有限公司 | 一类芳杂环类化合物及其制备方法和用途 |
| CN117466808B (zh) * | 2023-12-27 | 2024-03-12 | 烟台新药创制山东省实验室 | 一种6-烷基-2,4-二羟基吡啶类衍生物的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0708772B1 (en) * | 1993-07-15 | 2000-08-23 | Minnesota Mining And Manufacturing Company | IMIDAZO [4,5-c]PYRIDIN-4-AMINES |
| ATE283855T1 (de) * | 1996-07-03 | 2004-12-15 | Sumitomo Pharma | Neue purinderivate |
| US7157465B2 (en) * | 2001-04-17 | 2007-01-02 | Dainippon Simitomo Pharma Co., Ltd. | Adenine derivatives |
| WO2002088121A1 (en) * | 2001-04-27 | 2002-11-07 | Eisai Co., Ltd. | Pyrazolo[1,5-a]pyridines and medicines containing the same |
| MXPA04012199A (es) * | 2002-06-07 | 2005-02-25 | 3M Innovative Properties Co | Imidazopiridinas sustituidas con eter. |
| KR101312736B1 (ko) * | 2003-02-27 | 2013-09-27 | 팔라우 파르마 에스에이 | 피라졸로피리딘 유도체 |
| US7517887B2 (en) * | 2003-04-09 | 2009-04-14 | General Atomics | Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof |
| JP2005089334A (ja) * | 2003-09-12 | 2005-04-07 | Sumitomo Pharmaceut Co Ltd | ８−ヒドロキシアデニン化合物 |
| ATE423117T1 (de) * | 2003-09-22 | 2009-03-15 | Janssen Pharmaceutica Nv | Heterocyclische 7-aminoalkylidenylchinolone und - naphthyridone |
| FR2860514A1 (fr) * | 2003-10-03 | 2005-04-08 | Sanofi Synthelabo | Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique |
| US7897767B2 (en) * | 2003-11-14 | 2011-03-01 | 3M Innovative Properties Company | Oxime substituted imidazoquinolines |
| WO2005051317A2 (en) * | 2003-11-25 | 2005-06-09 | 3M Innovative Properties Company | Substituted imidazo ring systems and methods |
| TW200616604A (en) * | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
| WO2007093901A1 (en) * | 2006-02-17 | 2007-08-23 | Pfizer Limited | 3 -deazapurine derivatives as tlr7 modulators |
-
2006
- 2006-09-01 CA CA002620933A patent/CA2620933A1/en not_active Abandoned
- 2006-09-01 KR KR1020087005146A patent/KR20080031496A/ko not_active Ceased
- 2006-09-01 RS RSP-2008/0128A patent/RS20080128A/sr unknown
- 2006-09-01 EA EA200800396A patent/EA200800396A1/ru unknown
- 2006-09-01 WO PCT/US2006/034427 patent/WO2007028129A1/en not_active Ceased
- 2006-09-01 US US12/065,490 patent/US20100152230A1/en not_active Abandoned
- 2006-09-01 CN CNA2006800319190A patent/CN101253173A/zh active Pending
- 2006-09-01 EP EP06802901A patent/EP1924581A1/en not_active Withdrawn
- 2006-09-01 AU AU2006287157A patent/AU2006287157A1/en not_active Abandoned
- 2006-09-01 BR BRPI0615250-3A patent/BRPI0615250A2/pt not_active IP Right Cessation
- 2006-09-01 JP JP2008529359A patent/JP4584335B2/ja not_active Expired - Fee Related
- 2006-09-01 MX MX2008002414A patent/MX2008002414A/es unknown
-
2008
- 2008-02-04 IL IL189262A patent/IL189262A0/en unknown
- 2008-02-19 ZA ZA200801645A patent/ZA200801645B/xx unknown
- 2008-02-26 EC EC2008008225A patent/ECSP088225A/es unknown
- 2008-02-29 MA MA30694A patent/MA29759B1/fr unknown
- 2008-02-29 CR CR9781A patent/CR9781A/es not_active Application Discontinuation
- 2008-02-29 TN TNP2008000099A patent/TNSN08099A1/fr unknown
- 2008-02-29 SV SV2008002832A patent/SV2009002832A/es not_active Application Discontinuation
- 2008-03-17 NO NO20081393A patent/NO20081393L/no not_active Application Discontinuation
-
2011
- 2011-10-20 US US13/277,619 patent/US20120035209A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1924581A1 (en) | 2008-05-28 |
| US20100152230A1 (en) | 2010-06-17 |
| RS20080128A (sr) | 2009-05-06 |
| CA2620933A1 (en) | 2007-03-08 |
| CN101253173A (zh) | 2008-08-27 |
| BRPI0615250A2 (pt) | 2011-05-10 |
| MA29759B1 (fr) | 2008-09-01 |
| WO2007028129A1 (en) | 2007-03-08 |
| ECSP088225A (es) | 2008-03-26 |
| JP4584335B2 (ja) | 2010-11-17 |
| IL189262A0 (en) | 2008-06-05 |
| TNSN08099A1 (fr) | 2009-07-14 |
| EA200800396A1 (ru) | 2008-08-29 |
| AU2006287157A1 (en) | 2007-03-08 |
| JP2009507036A (ja) | 2009-02-19 |
| CR9781A (es) | 2008-03-26 |
| NO20081393L (no) | 2008-05-28 |
| ZA200801645B (en) | 2010-08-25 |
| KR20080031496A (ko) | 2008-04-08 |
| SV2009002832A (es) | 2009-02-19 |
| US20120035209A1 (en) | 2012-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2008002414A (es) | 1h-imidazopiridinas sustituidas con hidroxi y procedimientos. | |
| WO2006086449A3 (en) | Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines | |
| WO2007106854A3 (en) | Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods | |
| SG149828A1 (en) | Alkoxy substituted imidazoquinolines | |
| WO2007056112A3 (en) | Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods | |
| TW200639172A (en) | Pyrazolopyridines and analogs thereof | |
| MY145983A (en) | Aryloxy and arylalkyleneoxy substituted imidazoquinolines | |
| WO2005018556A3 (en) | Hydroxylamine substituted imidazo-containing compounds | |
| SG148201A1 (en) | Substituted imidazo ring systems and methods | |
| WO2006091568A3 (en) | Hydroxyalkyl substituted imidazonaphthyridines | |
| WO2006086633A3 (en) | Substituted fused [1,2]imidazo[4,5-c] ring compounds and methods | |
| WO2007143526A3 (en) | Substituted tetrahydroimidazonaphthyridines and methods | |
| WO2006098852A3 (en) | Hydroxyalkyl substituted imidazoquinolines | |
| WO2006091647A3 (en) | Method of preferentially inducing the biosynthesis of interferon | |
| SG149829A1 (en) | Pyrazolopyridines and analogs thereof | |
| PL1789042T3 (pl) | Układy pierścieni 1-alkoksy 1H-imidazo i sposoby | |
| WO2006038923A3 (en) | Aryl substituted imidazonaphthyridines | |
| WO2005076783A3 (en) | Sulfone substituted imidazo ring ethers | |
| WO2005048945A3 (en) | Hydroxylamine substituted imidazo ring compounds | |
| WO2006107853A3 (en) | Pyrazolopyridine-1,4-diamines and analogs thereof | |
| WO2005048933A3 (en) | Oxime substituted imidazo ring compounds | |
| WO2006026760A3 (en) | 1-amino imidazo-containing compounds and methods | |
| WO2006091394A3 (en) | Substituted imidazoquinolines and imidazonaphthyridines | |
| WO2006091567A3 (en) | Hydroxyalkyl substituted imidazoquinoline compounds and methods | |
| TW200505458A (en) | 1-amino 1h-imidazoquinolines |